Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Sizheng ZHAO"'
Autor:
Catherine Smith, Andrew Cope, Elena Nikiphorou, Mrinalini Dey, James Galloway, Kimme L Hyrich, Katie Bechman, Sizheng Zhao
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective Serious infection remains a concern when prescribing immune-modulatory drugs for immune-mediated inflammatory diseases. The ‘summary of product characteristics’ (SmPCs) provide information on adverse events for example, infections, from
Externí odkaz:
https://doaj.org/article/f084e6b6c15b4020ba7a7c5ae3966d8d
Autor:
George E Fragoulis, Jan Schoones, Delphine Courvoisier, Elena Nikiphorou, Mrinalini Dey, James Galloway, Kimme L Hyrich, Sizheng Zhao
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective To conduct a systematic literature review (SLR) on the screening and prophylaxis of opportunistic and chronic infections in autoimmune inflammatory rheumatic diseases (AIIRD).Methods SLR (inception-12/2021) based on the following search dom
Externí odkaz:
https://doaj.org/article/8e26ce84333d446fbbc71b761a657e7a
Autor:
Sizheng Zhao, Daniel Thong, Natasha Miller, Stephen J. Duffield, David M. Hughes, Laura Chadwick, Nicola J. Goodson
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Abstract Background Depression is common among patients with axial spondyloarthritis (axSpA), but reports of its prevalence are highly variable. We performed a systematic review to (i) describe the prevalence of depression in axSpA, (ii) compare its
Externí odkaz:
https://doaj.org/article/56afe554399b466da7b4e9305e8d6a04
Autor:
Houchen Lyu, Sizheng Zhao, Jiatian Li, Xiaoxiao Li, Yilun Wang, Dongxing Xie, Chao Zeng, Guanghua Lei, Jie Wei, Hui Li
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 107:e3366-e3373
Context Recent meta-analyses of randomized controlled trials have raised concerns that denosumab might increase the risk of infection. However, data of denosumab on the risk of community-acquired pneumonia are sparse. Objective This work aimed to exa
Autor:
Yu Heng Kwan, Jie Kie Phang, Ting Hui Woon, Jean Liew, Maureen Dubreuil, Fabian Proft, Sofia Ramiro, Anna Molto, Victoria Navarro-Compan, Manouk De Hooge, Bhowmik Meghnathi, Nelly Ziade, Steven Sizheng Zhao, Maria Llop, Xenofon Baraliakos, Warren Fong
BACKGROUND The use of social media in healthcare may serve as a beneficial tool for education, information dissemination, telemedicine, research, networking and communications. To better leverage on the benefits of social media, it is imperative to u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::445471f1e67390d663d87df84bccd331
https://doi.org/10.2196/preprints.39155
https://doi.org/10.2196/preprints.39155
Autor:
Mrinalini Dey, Katie Bechman, Sizheng Zhao, George E Fragoulis, Catherine Smith, Andrew Cope, Elena Nikiphorou, Kimme L Hyrich, James Galloway
Publikováno v:
Dey, M, Bechman, K, Zhao, S S, Fragoulis, G E, Smith, C H, Cope, A, Nikiphorou, E, Hyrich, K L & Galloway, J 2022, ' Infection profile of immune-modulatory drugs used in autoimmune diseases: Analysis of summary of product characteristic data ', RMD Open .
ObjectiveSerious infection remains a concern when prescribing immune-modulatory drugs for immune-mediated inflammatory diseases. The ‘summary of product characteristics’ (SmPCs) provide information on adverse events for example, infections, from
Autor:
Fragoulis, George E., Dey, Mrinalini, Sizheng Zhao, Schoones, Jan, Courvoisier, Delphine, Galloway, James, Hyrich, Kimme L., Nikiphorou, Elena
Publikováno v:
RMD Open; Dec2022, Vol. 8 Issue 2, p1-16, 16p
Autor:
Dey, Mrinalini, Bechman, Katie, Sizheng Zhao, Fragoulis, George E., Smith, Catherine, Cope, Andrew, Nikiphorou, Elena, Hyrich, Kimme L., Galloway, James
Publikováno v:
RMD Open; Dec2022, Vol. 8 Issue 2, p1-8, 8p
Autor:
Sizheng Zhao, Bradley Pittam, Nicholas L Harrison, Ashar E Ahmed, Karishma Nursiah, Nicola J Goodson, David M Hughes
Background. Delay to diagnosis in axial spondyloarthritis (axSpA) is longer than many other rheumatic diseases. Prolonged delay has been shown to associate with poorer outcomes including functional impairment and quality of life. Our aims were to des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ffdbab8357a82a5767d30d6202250c
https://doi.org/10.21203/rs.3.rs-17943/v2
https://doi.org/10.21203/rs.3.rs-17943/v2
Autor:
Karishma Nursiah, Bradley Pittam, Sizheng Zhao, Nicola J Goodson, David M Hughes, Ashar E Ahmed, Nicholas L Harrison
Background . Delay to diagnosis in axial spondyloarthritis (axSpA) is longer than many other rheumatic diseases. Prolonged delay has been shown to associate with poorer outcomes including functional impairment and quality of life. Our aims were to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::040ac3f26ff8b981933a479859218e76
https://doi.org/10.21203/rs.3.rs-17943/v1
https://doi.org/10.21203/rs.3.rs-17943/v1